---
title: "Sito Bio released its performance for the first half of the year, turning from profit to a loss of 52.6871 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254435567.md"
description: "According to the Zhitong Finance APP, Sito Bio released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 508 million yuan, a year-on-year decrease of 10.39%. The net loss attributable to shareholders of the listed company was 52.6871 million yuan. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 53.4816 million yuan. The basic loss per share was 0.28 yuan"
datetime: "2025-08-25T11:47:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254435567.md)
  - [en](https://longbridge.com/en/news/254435567.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254435567.md)
---

# Sito Bio released its performance for the first half of the year, turning from profit to a loss of 52.6871 million yuan

According to the Zhitong Finance APP, Sito Bio (300583.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 508 million yuan, a year-on-year decrease of 10.39%. The net loss attributable to shareholders of the listed company was 52.6871 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 53.4816 million yuan. The basic loss per share was 0.28 yuan

### Related Stocks

- [300583.CN](https://longbridge.com/en/quote/300583.CN.md)

## Related News & Research

- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [SOUTHAMPTON WILL NOT PLAY IN CHAMPIONSHIP PLAYOFF FINAL AFTER APPEAL REJECTED- EFL STATEMENT](https://longbridge.com/en/news/287118852.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)